Abstract:This study aimed to analyze the clinical characteristics, cell types, and molecular characteristics of the tumor microenvironment to better predict the prognosis of neuroblastoma (NB). The gene expression data and corresponding clinical information of 498 NB patients were obtained from the Gene Expression Omnibus (GEO: GSE62564) and ArrayExpress (accession: E-MTAB-8248). The relative cell abundances were estimated using single-sample gene set enrichment analysis (ssGSEA) with the R gene set variation analysis (GSVA) package. We performed Cox regression analyses to identify marker genes indicating cell subsets and combined these with prognostically relevant clinical factors to develop a new prognostic model. Data from the E-MTAB-8248 cohort verified the predictive accuracy of the prognostic model. Single-cell RNA-seq data were analyzed by using the R Seurat package. Multivariate survival analysis for each gene, using clinical characteristics as cofactors, identified 34 prognostic genes that showed a significant correlation with both event-free survival (EFS) and overall survival (OS) (log-rank test, P value < 0.05). The pathway enrichment analysis revealed that these prognostic genes were highly enriched in the marker genes of NB cells with mesenchymal features and protein translation. Ultimately, USP39, RPL8, IL1RAPL1, MAST4, CSRP2, ATP5E, International Neuroblastoma Staging System (INSS) stage, age, and MYCN status were selected to build an optimized Cox model for NB risk stratification. These samples were divided into two groups using the median of the risk score as a cutoff. The prognosis of samples in the poor prognosis group (PP) was significantly worse than that of samples in the good prognosis group (GP) (log-rank test, P value < 0.0001, median EFS: 640.5 vs. 2247 days, median OS: 1279.5 vs. 2519 days). The risk model was also regarded as a prognostic indicator independent of MYCN status, age, and stage. Finally, through scRNA-seq data, we found that as an important prognostic marker, USP39 might participate in the regulation of RNA splicing in NB. Our study established a multivariate Cox model based on gene signatures and clinical characteristics to better predict the prognosis of NB and revealed that mesenchymal signature genes of NB cells, especially USP39, were more abundant in patients with a poor prognosis than in those with a good prognosis. KEY MESSAGES: Our study established a multivariate Cox model based on gene signatures and clinical characteristics to better predict the prognosis of NB and revealed that mesenchymal signature genes of NB cells, especially USP39, were more abundant in patients with a poor prognosis than in those with a good prognosis. USP39, RPL8, IL1RAPL1, MAST4, CSRP2, ATP5E, International Neuroblastoma Staging System (INSS) stage, age, and MYCN status were selected to build an optimized Cox model for NB risk stratification. These samples were divided into two groups using the median of the risk score as a cutoff. The prognosis of samples in the poor prognosis group (PP) was significantly worse than that of samples in the good prognosis group (GP). Finally, through scRNA-seq data, we found that as an important prognostic marker, USP39 might participate in the regulation of RNA splicing in NB.

The Role of Wnt1 Signaling Pathway in the Oncogenic Transformation and Invasion of Neuroblastomas

WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma

Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma

Activated Beta-Catenin Forces N2a Cell-Derived Neurons Back To Tumor-Like Neuroblasts And Positively Correlates With A Risk For Human Neuroblastoma

bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma

Identification of prognostic biomarkers in neuroblastoma using WGCNA and multi-omics analysis

The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development

Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma

Expressions of Wnt related genes in the development of nephroblastoma

NEAT1 Negatively Regulates Cell Proliferation and Migration of Neuroblastoma Cells by Mir-183-5p/foxp1 Via the ERK/AKT Pathway.

Neuroblastoma: clinical and biological approach to risk stratification and treatment

High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma

Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma

Neuronatin Promotes the Progression of Non-Small Cell Lung Cancer by Activating the NF-κB Signaling

Wnt signaling pathway analysis in renal cell carcinoma in young patients

Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

The Angiogenesis of Neuroblastoma and VEGF,FLT-1 Expression

Oncogene or tumor suppressor gene: An integrated pan-cancer analysis of NBPF1

Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification

Expression of ADRB2 in children with neuroblastoma and its influence on prognosis

Neuroblastoma Management in Chinese Children